242 — Plainview, New York

242 is a clinical research site located in Plainview, New York, United States.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

242 has participated in 2 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma SA, UCB Pharma.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 242?

242 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 242 conducted?

242 has 2 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 242 accredited by Crixeo Health?

242 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 242?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.